D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-0.54%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$78.3B
AUM Growth
-$8.57B
Cap. Flow
-$15.7B
Cap. Flow %
-20.09%
Top 10 Hldgs %
12.12%
Holding
4,250
New
658
Increased
1,320
Reduced
1,320
Closed
553

Sector Composition

1 Technology 20.28%
2 Consumer Discretionary 13.97%
3 Healthcare 10.06%
4 Financials 9.79%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SWIR
3126
DELISTED
Sierra Wireless
SWIR
$179K ﹤0.01%
+11,535
New +$179K
ENIA
3127
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
$177K ﹤0.01%
+30,323
New +$177K
AFAQ
3128
DELISTED
AF Acquisition Corp. Class A Common Stock
AFAQ
$176K ﹤0.01%
+18,113
New +$176K
MBAC.WS
3129
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$176K ﹤0.01%
131,498
+48,165
+58% +$64.5K
GLNG icon
3130
Golar LNG
GLNG
$4.09B
$174K ﹤0.01%
+13,430
New +$174K
CORZ
3131
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$174K ﹤0.01%
17,188
-39,902
-70% -$404K
BRKL
3132
DELISTED
Brookline Bancorp
BRKL
$173K ﹤0.01%
+11,353
New +$173K
EQX icon
3133
Equinox Gold
EQX
$8.13B
$173K ﹤0.01%
26,285
-7,627
-22% -$50.2K
USX
3134
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$173K ﹤0.01%
20,100
-18,648
-48% -$161K
ZUO
3135
DELISTED
Zuora, Inc.
ZUO
$171K ﹤0.01%
10,306
-27,446
-73% -$455K
PCPC.WS
3136
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$171K ﹤0.01%
112,500
BENE
3137
DELISTED
Benessere Capital Acquisition Corp. Class A Common Stock
BENE
$171K ﹤0.01%
+16,972
New +$171K
JOBY.WS icon
3138
Joby Aviation, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
JOBY.WS
$166K ﹤0.01%
+73,750
New +$166K
ORGS
3139
DELISTED
Orgenesis Inc. Common Stock
ORGS
$166K ﹤0.01%
+3,360
New +$166K
SPTKW
3140
DELISTED
SportsTek Acquisition Corp. Warrant
SPTKW
$166K ﹤0.01%
184,805
+22,305
+14% +$20K
WRAC.WS
3141
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$165K ﹤0.01%
+330,000
New +$165K
ONMDW icon
3142
OneMedNet Corp Warrant
ONMDW
$1.22M
$164K ﹤0.01%
+420,000
New +$164K
BGSX.WS
3143
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$164K ﹤0.01%
250,000
+199,597
+396% +$131K
BV icon
3144
BrightView Holdings
BV
$1.29B
$162K ﹤0.01%
10,976
-39,906
-78% -$589K
ORC
3145
Orchid Island Capital
ORC
$1.03B
$162K ﹤0.01%
+6,629
New +$162K
REVB icon
3146
Revelation Biosciences
REVB
$2.65M
0
-$161K
NBSE
3147
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$162K ﹤0.01%
2,240
-659
-23% -$47.7K
BCEL
3148
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$162K ﹤0.01%
26,022
+12,527
+93% +$78K
SHQAW
3149
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$162K ﹤0.01%
+325,000
New +$162K
CIM
3150
Chimera Investment
CIM
$1.14B
$161K ﹤0.01%
3,611
-4,771
-57% -$213K